1. Biosimilar DMARDs: What Does the Future Hold?

   • Filipe Araújo
   • João Gonçalves
   • João Eurico Fonseca

   Current Opinion 03 March 2016 Pages: 629 - 637

2. The Emerging Role of PI3K Inhibitors in the Treatment of Hematological Malignancies: Preclinical Data and Clinical Progress to Date

   • Till Seiler
   • Grit Hutter
   • Martin Dreyling

   Leading Article 06 April 2016 Pages: 639 - 646

   

3. Pharmacotherapy for Neonatal Seizures: Current Knowledge and Future Perspectives

   • Maria D. Donovan
   • Brendan T. Griffin
   • Geraldine B. Boylan

   Review Article 04 March 2016 Pages: 647 - 661

   

4. Beyond TNF Inhibitors: New Pathways and Emerging Treatments for Psoriatic Arthritis

   • Ennio Lubrano
   • Fabio Massimo Perrotta

   Review Article 08 March 2016 Pages: 663 - 673

   

5. Nail Psoriasis: A Review of Treatment Options

   • Marcel C. Pasch

   Review Article Open access 04 April 2016 Pages: 675 - 705

   

6. Eslicarbazepine Acetate Monotherapy: A Review in Partial-Onset Seizures

   • Matt Shirley
   • Sohita Dhillon

   Adis Drug Evaluation 07 April 2016 Pages: 707 - 717

   

7. Sublingual Sufentanil: A Review in Acute Postoperative Pain

   • James E. Frampton

   Adis Drug Evaluation 11 April 2016 Pages: 719 - 729

   

8. Erratum to: What to Do, and What Not to Do, When Diagnosing and Treating Breakthrough Cancer Pain (BTcP): Expert Opinion

   • Working Group Nientemale DEI
   • R. Vellucci
   • P. Romualdi

   Erratum 07 April 2016 Pages: 731 - 732